ettsia exhibits serotypic and ecological specificities (table 1) . In particular, it has been found in Asia, Europe, and Africa [2, 5, 6] , whereas R. sibirica, the agent of North Asian tick typhus, is confined to Siberia and western China [7] [8] [9] . In this study, we will refer to it as "R. sibirica mongolotimonae" and to the agent of North Asian tick typhus as "R. sibirica sensu stricto." R. sibirica mongolotimonae was first isolated in Beijing from Hyalomma asiaticum ticks collected in the Alashian region of Inner Mongolia in 1991 [2] . In 1996, we diagnosed the first case of human infection in southern France in a woman who presented with a febrile rash and a single inoculation eschar in the groin [6] . In 2000, we diagnosed a second human case in a man who developed an inoculation eschar on the leg, fever, and lymphangitis expanding from the eschar to an enlarged and painful lymph node in the groin [3] . Re- Characteristic, by class R. sibirica mongolotimonae (PR) [3, 6] R. sibirica sensu stricto [7] [8] [9] Epidemiological characteristic
Recognized tick vectors Hyalomma asiaticum [2] , Hyalomma truncatum [38] Dermacentor marginatus, Dermacentor nuttali, Dermacentor silvarum [39] , Dermacentor pictus [7] , Dermacentor sinicus, Dermacentor auratus, Haemaphysalis concinna, Hyalomma wellingtoni, Hyalomma yeni [40] Geographic area(s) of endemicity Algeria (PR), China [31] , France (PR), Niger [38] , and South Africa [41] Siberia [8] and Western China [42, 43] cently, a third case was diagnosed in South Africa in a man who developed an inoculation eschar on a toe, fever, headache, and lymphangitis expanding from the eschar to an enlarged inguinal lymph node [10] . Since 2000, we have diagnosed in our laboratory an additional 7 human cases by culture and/or PCR plus serological testing. The aim of this study was to describe the epidemiological and clinical characteristics of our 7 new patients, together with those from the literature, and to compare these characteristics with those associated with the major tick-borne rickettsioses worldwide to further characterize the pathogenic role of R. sibirica mongolotimonae.
PATIENTS AND METHODS
Study design. Appropriate informed consent was obtained from all patients. From January 1996 to June 2004, we prospectively studied serum specimens and, when available, skin biopsy and/or whole-blood samples obtained from patients with a suspected arthropod-borne infection referred to our laboratory. Then, we compared the epidemiological and clinical features of patients who fulfilled the diagnostic criteria described below for R. sibirica mongolotimonae infection with those of patients with the main rickettsioses diagnosed in France at our center (i.e., Mediterranean spotted fever [MSF] and tick-borne lymphadenopathy [TIBOLA]). We also compared these features with those associated with African tickbite fever (ATBF), which is the most frequent traveler-associated rickettsiosis diagnosed in our laboratory. Subsequently, we also compared R. sibirica mongolotimonae infection with large published series of the main tick-borne rickettsioses worldwide to define its clinical characteristics.
Case definition. A definite diagnosis of infection with R. sibirica mongolotimonae was made on the basis of the isolation of this rickettsia from clinical specimens or the association of a PCR result and serological test result positive for R. sibirica mongolotimonae. Patients with MSF, TIBOLA, and ATBF were classified as having definite cases when they fulfilled the previously described diagnostic criteria, including epidemiological and clinical criteria, and had positive culture and serological test results [11] [12] [13] [14] . PCR results were also considered among diagnostic criteria [15] . For each patient, epidemiological and clinical data were collected by the consulting physician with use of a standardized questionnaire at the time of clinical examination.
Serological tests. For each patient, an acute-phase serum sample was obtained within 2 weeks after the onset of symptoms and, when possible, a convalescent-phase serum sample
Rickettsia africae (PR)
Rickettsia rickettsii [44] Rickettsia japonica [38] Rickettsia australis [45] Rickettsia heilongjiangensis [41] Amblyomma 
(i.e., one collected 12 weeks after onset of symptoms) was also obtained. IgG and IgM antibody titers were estimated with use of the microimmunofluorescence (MIF) assay, as reported elsewhere [16] . We used the following antigens: for patients infected in France, we used R. sibirica mongolotimonae strain HA-91, ATCC VR-1526 [2] , Rickettsia conorii strain Malish, ATCC VR-613 [17] , Rickettsia slovaca strain 13B [18] , Rickettsia helvetica strain C9P9 [19] , Rickettsia massiliae strain Mtu1 [20] , and Rickettsia felis strain Marseille, ATCC VR-1525 [21] ; for patients returning from sub-Saharan Africa, we used Rickettsia africae strain ESF-5, R. conorii strain Malish, Rickettsia aeschlimannii strain MC16, R. sibirica mongolotimonae strain HA-91, Rickettsia akari strain MK, and R. felis strain Marseille; in addition, to estimate the degree of cross-reactivity within the R. sibirica species, we also used R. sibirica sensu stricto strain 246, ATCC VR151T [22] . Titers of 1:64 for IgG and 1:32 for IgM were used as cutoff values. Western blotting procedures were performed as described elsewhere [23] with use of R. sibirica mongolotimonae and R. sibirica sensu stricto antigens. Serological evidence of infection with R. sibirica mongolotimonae was considered to be present when IgG and IgM titers were at least 2 serial dilutions higher for R. sibirica mongolotimonae than for other tested rickettsiae, including R. sibirica sensu stricto, or when the western blot profile showed only antibodies to R. sibirica mongolotimonae.
Culture. Attempted cultivation of rickettsiae from skin biopsy specimens and heparinized blood samples was performed using the shell-vial cell culture technique, as previously reported [24] .
PCR amplification and sequencing. DNA was extracted from EDTA blood specimens and ground skin biopsy samples by using the QIAamp Tissue Kit (Qiagen) according to the manufacturer's recommendations. These extracts were used as templates in previously described PCR assays incorporating the primers 190-70 and 190-701, which amplify a 630-bp fragment of the ompA gene [25] , and 877F and 1258R, which amplify a 381-bp fragment of the gltA gene [26] . As negative controls, we used sterile water processed as described above and DNA extracted from a heart valve from a patient with degenerative valvulopathy that was incorporated into every 6 specimens. As positive control, we used DNA from Rickettsia montanensis strain M/5-6 [27] . Testing was done blindly. When regular PCR performed using the skin biopsy sample had negative results or when an acute-phase serum sample (but no skin biopsy sample) was available, we performed a nested PCR incorporating the ompA-amplifying primer sets AF1F-AF1R and AF2F- AF2R for the nested amplification, as described elsewhere [12, 15] . We incorporated the above-described negative controls in every 6 specimens. To avoid contamination, we did not include any positive control in this assay. All positive PCR products were sequenced in both directions, as described elsewhere [28] . The epidemiological, clinical, and microbiologic features of the 7 patients are detailed in table 2.
Histopathological and immunohistochemical testing. The eschar biopsy sample from patient 5 was formalin-fixed, paraffin-embedded, and then cut to 3-mm thickness and stained with hematoxylin-eosin-saffron with use of routine staining methods. Serial sections were also obtained to perform immunohistochemical investigations, as described elsewhere [29] , using mouse antiserum produced against R. sibirica mongolotimonae [2] . A skin biopsy sample obtained from a patient with psoriasis was used as a negative control and was processed as described above.
Statistical analysis. To estimate the specificity of clinical characteristics of R. sibirica mongolotimonae infection, we conducted a statistical comparison of patients with MSF, TIBOLA, and ATBF whose diagnosis was made in our laboratory (Unite des Rickettsies; Marseille, France) with a large published series of patients with RMSF, Siberian tick typhus, Japanese spotted fever, Queensland tick typhus, and Rickettsia heilongjiangensis infection (table 3) using Fisher's exact test. The seasonality of rickettsioses in France was further studied by comparing R. sibirica mongolotimonae infection with MSF and TIBOLA after stratification of patients according to the season during which they developed the disease. Observed differences were considered significant when P was !.05 for 2-tailed tests.
RESULTS

R. sibirica mongolotimonae infection.
From January 1996 through June 2004, 9 patients had cases that we diagnosed as fulfilling our case definition for R. sibirica mongolotimonae infection, including 2 patients whose cases have previously been reported [3, 6] . In the 7 patients whose cases had not previously been reported, the diagnosis of infection with R. sibirica mongolotimonae was made on the basis of a positive culture result in 3 cases and on an association of positive PCR results and a specific antibody response in 4 cases (table 2). Six of the cases occurred during the spring, and only 1 infection occurred during the summer (in early July). Six patients lived in southern France, and 1 patient had recently returned from a trip to southern Algeria. Four patients were male, and 3 patients were female. The median age of the patients was 55 years (range, 21-70 years). A Tick bite or tick-handling was reported by 3 patients, but no tick was collected for further examination. In France, contact with ticks occurred for 5 patients in their garden and for 1 patient during a walk in the Camargue National Park. In Algeria, the patient had contacts with camel ticks but did not remember receiving any tick bites. The median incubation time was 5 days (range, 3-6 days). Symptoms at onset included fever in all patients (temperature range, 38.8ЊC-39.5ЊC), myalgias in 6 patients, and headache in 4 patients. Four patients developed a single inoculation eschar on the lower or upper limbs or on the trunk. Two patients presented with 2 eschars (figure 2). One patient developed no eschar but did develop an enlarged lymph node and lymphangitis in the territory draining the tick-bite site on the leg. Another 3 patients each presented with an enlarged lymph node in the territory draining the eschar, including 2 patients who also had lymphangitis expanding from the eschar to the draining node. Our initial diagnosis for the first 5 patients from France was spotted fever rickettsiosis. The presence of lymphangitis expanding from the eschar to the draining lymph node in patient 6 (table 2) led 2 of the investigators (D.R. and P.B.) to clinically suspect infection with R. sibirica mongolotimonae. Five patients developed a generalized maculopapular rash involving the palms and soles but not the face, and 1 patient had a dozen maculopapular spots on the trunk. Six patients were administered oral doxycycline, and 1 patient received amoxicillin. The 7 patients recovered without any sequelae.
The results of serological testing with MIF were positive for 4 of the 7 patients (table 2). One of the 4 patients with positive titers (patient 2) had a 4-fold higher titer to R. sibirica mongolotimonae (IgG titer, 1:512; IgM titer, 1:128) than to other tested rickettsiae, including R. sibirica sensu stricto (IgG titer, 1:128; IgM titer, 1:128). In the other 3 cases, MIF titers to all tested antigens were identical. In 3 patients, the Western blot demonstrated the presence of antibodies to high-molecular weight proteins (rOmpA and rOmpB) of R. sibirica mongolotimonae only. Another 3 patients had antibodies specifically directed against R. sibirica mongolotimonae after serum crossadsorption with R. sibirica sensu stricto ( figure 3 ). Altogether, 6 of 7 patients exhibited a specific serological reaction to R. sibirica mongolotimonae. Skin biopsy samples were the most useful specimens for both PCR (with 5 of 5 patients having positive results) and culture (with 3 of 5 patients positive for R. sibirica mongolotimonae). The histopathological features of the inoculation eschar from patient 5 were dominated by the presence of endothelial swelling, mural and occlusive fibrin thrombi observed in a few blood vessels, dermal edema, and cutaneous necrosis. Intramural and perivascular infiltration by polymorphonuclear leukocytes, small lymphocytes, and macrophages were also observed. Rickettsiae were detected by immunohistochemical analysis in the endothelium and in inflammatory cells organized in and around the blood vessels (figure 4). The rickettsia was also cultivated from blood samples obtained from patient 7. In addition, nested PCR of serum samples from 3 patients (including 2 patients for whom no skin biopsy sample was available) yielded positive results. R. sibirica mongolotimonae was identified on the basis of a 100% similarity in ompA nucleotide sequence for French isolates and amplicons and a 99.9% similarity for the Algerian isolate, with sequences available in GenBank for R. sibirica mongolotimonae.
Other tick-borne rickettsioses. From January 1996 through June 2004, we also diagnosed 121 cases of definite MSF (85 of which occurred in patients who were infected in southern France), 68 cases of definite TIBOLA (58 of which occurred in patients who were infected in southern France), and 139 cases of definite ATBF. The epidemiological and clinical characteristics of the patients are detailed in table 3.
Statistical comparison. In comparison with MSF and TI-BOLA, R. sibirica mongolotimonae infection exhibited specific features, including occurrence in the spring ( and P ! .01 P p , respectively), occurrence of lymphangitis ( for both .02 P ! .01 diseases), and the presence of multiple eschars ( and P ! .01 , respectively) (table 3). The presence of enlarged lymph P p .01 nodes was significantly more common in patients with R. sibirica mongolotimonae infection than in patients with MSF ( ) and was significantly less common in patients with R. P ! .01 sibirica mongolotimonae infection than in patients with TIBOLA ( ). TIBOLA was also associated with significantly fewer P ! .01 instances of fever ( ) and rash ( ) than was R. sibirica P ! .01 P ! .01 mongolotimonae infection. When compared with other major rickettsioses worldwide, 2 features of R. sibirica mongolotimonae infection appeared unusual: the presence of lymphangitis (which occurs in no other major rickettsioses except for R. heilongjiangensis infection) and multiple eschars (which occurs in no other major rickettsioses except for ATBF). In addition, the development of a headache was significantly more common in patients with R. sibirica mongolotimonae infection than in patients with ATBF ( ), but it was significantly less com-P ! .01 mon in patients with R. sibirica mongolotimonae infection than in patients with Rocky Mountain spotted fever ( ) or R. P p .03 heilongjiangensis infection ( ); significantly more patients P p .04 with R. sibirica mongolotimonae infection than patients with TIBOLA were febrile ( ); and patients with R. sibirica P ! .01 mongolotimonae infection developed a cutaneous rash significantly more frequently than did patients with TIBOLA (P ! ) but significantly less frequently than did patients with Jap-.01 anese spotted fever ( ). P p .04
DISCUSSION
In this report, we describe the epidemiological and clinical characteristics of R. sibirica mongolotimonae infection on the basis of data from 9 patients who received that diagnosis in our laboratory, including 7 new patients. Six of our 7 new patients exhibited specific serological evidence of R. sibirica mongolotimonae infection. Of these 6 patients, only 1 exhibited an MIF antibody response specifically directed against R. sibirica mongolotimonae. With use of Western blot, we observed in another 3 patients an early antibody response specifically directed against high-molecular weight proteins of R. sibirica mongolotimonae. The higher specificity of early antibodies for high-molecular weight, surface-exposed antigens has previously been observed for other rickettsioses [23, 30] . In 4 patients, the specificity of antibodies for these high-molecular weight proteins of R. sibirica mongolotimonae was demonstrated using cross-adsorption followed by Western blot (figure 3). We confirm that high-molecular weight, surface-exposed proteins of R. sibirica mongolotimonae exhibit an antigenic specificity that elicits in humans, as in mice [31] , a specific antibody response. Culture and PCR of the eschar biopsy sample established the diagnosis in 5 patients, including 1 patient in whom the rickettsia was also isolated from blood samples. Nested PCR of serum samples [15] led to the diagnosis in an additional 2 patients. With use of immunohistochemical tests, we could also detect the rickettsia in 1 eschar biopsy sample.
In France, infection with R. sibirica mongolotimonae occurred in the spring for 5 patients and in the beginning of summer for 1 patient. The 2 French patients with previously reported cases had also developed the disease in the spring [3, 6] . The patient who was infected in Algeria was infected in April, and the patient who was infected in South Africa was hospitalized in September [10] . In southern France, the time of outbreak of R. sibirica mongolotimonae infection (in the spring) was significantly different from that of the other 2 rickettsioses endemic in the area, MSF due to R. conorii ( ) and TIBOLA P ! .01 due to R. slovaca ( ); these 2 diseases mostly occur in P p .02 the summer and the winter, respectively [13, 32] . In Algeria, Mediterranean spotted fever, the main tick-borne spotted fever rickettsiosis, also occurs in the summer.
When combining the clinical data from our 7 cases with clinical data from the 2 previously published French cases [3, 6] , the median incubation period was 6 days (range, 3-8 days). The clinical presentation in most of the cases included fever (temperature, 138.5ЊC), eschar(s), and a generalized maculopapular rash. When compared with definite cases of MSF and TIBOLA diagnosed in our laboratory (table 3), R. sibirica mongolotimonae infection represented 6% of diagnosed rickettsioses in the area and was characterized by the unusual features of enlarged lymph nodes in the territory draining the eschar ( ) and lymphangitis expanding from the eschar to the P ! .01 draining node ( ). The South African patient also pre-P ! .01 sented with an enlarged lymph node and lymphangitis [10] . Therefore, lymphangitis, which was found in 5 (50%) of 10 of the reported patients, may be considered relatively typical. In fact, 2 of the investigators (D.R. and P.B.) clinically identified the disease in a patient on the basis of the assumption that the lymphangitis was specific. Therefore, we propose that this disease be named "lymphangitis-associated rickettsiosis." In addition, 2 patients from our series presented with 2 inoculation eschars (figure 2), a feature rarely encountered in patients with MSF in our laboratory ( ) [32, 33] , and in TIBOLA P ! .01 ( ) [13] . No severe cases were noted, because all patients P p .01 recovered without any sequelae. Infection with R. sibirica mongolotimonae also differed significantly from other rickettsioses frequently encountered worldwide because it is the only one (with the exception of R. heilongjiangensis infection) characterized by the presence of lymphangitis (found in 15% of cases) and the only one (with the exception of ATBF) characterized by multiple eschars (table 3) . Unfortunately, no statistical comparison was possible with North Asian tick typhus caused by R. sibirica sensu stricto [7] [8] [9] . Nevertheless, the occurrence of lymphangitis and multiple eschars appears to be differ between patients with R. sibirica sensu stricto infection and those with R. sibirica mongolotimonae infection (table 1) . When compared with nonrickettsial diseases, R. sibirica mongolotimonae should be considered a differential diagnosis of tularemia in patients who develop a nodular lymphangitis as a result of a tick bite [34] .
The presence of multiple eschars, as observed in 2 of our patients, is common in patients with ATBF [12] because of the hunter behavior of Amblyomma ticks (in response to stimuli, they specifically converge on nearby hosts) [31] , but it is unusual among patients with other rickettsioses. The presence of 2 eschars in our patients may be explained by the affinity of the tick-vector for humans. However, the vector of R. sibirica mongolotimonae has been identified in neither France nor South Africa to date. This rickettsia was initially isolated from H. asiaticum ticks in Inner Mongolia [2] and then isolated from Hyalomma truncatum in Niger [5] . In South Africa, H. truncatum ticks, abundant in the region and known to feed on humans, were suspected to be the vectors of R. sibirica mongolotimonae [35] . Hyalomma ticks are widely distributed in Asia and Africa and are also prevalent in southern Europe, including France [36] . Although the camel ticks that patient 7 had been in contact with were not identified, they could have been Hyalomma dromedarii, which are common camel ticks and have previously been shown to harbor rickettsiae [37] .
R. sibirica mongolotimonae causes a mild disease that we propose to name lymphangitis-associated rickettsiosis. It may be observed in Europe, Africa, and Asia. An active search for the vector of R. sibirica mongolotimonae in France will be conducted to complete our knowledge of the epidemiology of this rickettsiosis.
